Патофизиология и патоморфология ринита
Патофизиология и патоморфология ринита
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Bousquet J, Khaltaev N, Cruz AA et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008; 63 (Suppl. 86): 18–160.
2. Bousquet J, Fokkens W, Burney P et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008; 63: 842–53. doi:10.1111/j.1398-9995. 2008.01715.x
3. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its aetiology, evaluation, and treatment. ENT 2000; 79 (9): 690–702.
4. Van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy 2005; 60: 1471–81. doi:10.111 l/j.1398-9995.2005.00975.x
5. Lai D, Corey JP. Vasomotor rhinitis update. Curr Opin Otolaryngol Head Neck Surg 2004; 12 (3): 243–7. doi:10.1097/01. moo.0000122310.13359.79
6. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24: 147–54.
7. Bachert C. Persistent rhinitis-allergic or nonallergic? Allergy 2004; 59 (Suppl. 76): 11-15. doi:10.1111/j.0108-1675.2004.00389.x
8. Riechelmann H. Etagenwechsel und Folgeerkrankungen der allergischen Rhinitis. Laryngorhinootologie 1998; 77: 646–9. doi:10.1055/s-2007-997056
9. Fang SY, Shen CL. Neuropeptide innervation and neuroen-docrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998; 28: 228–32. doi:10.1046/j.1365-2222.1998. 00204.x
10. Heppt W, Preiser C, Cryer A et al. Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 2002; 44: 924–9. doi:10.1097/00043764-200210000-00011
11. Elwany S, Bumsted R. Ultrastructural observations on vaso-motor rhinitis. ORL 1987; 49: 199–205.
12. Gianessi F, Fattori B, Ursino F et al. Ultrastructural and ul-tracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 2003; 123: 943–9.
13. Numata T, Konno A, Hasegawa S et al. Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 1999; 119: 304–13. doi:10.1159/000024208
14. Sanico AM, Togias A. Noninfectious, nonallergic rhinitis NINAR: considerations on possible mechanisms. Am J Rhinol 1998; 12: 65–72. doi:10.2500/105065898782103043
15. Karlsson U, Schultz RL. Fixation of the central nervous system for electron microscopy by aldehyde perfusion. J Ultrastruct Res 1965; 12: 160–86. doi: 10.1016/80022-5320(65)80014-4
16. Powe DG, Jagger C, Kleinjan A et al. Entopy: localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003; 33: 1374–9. doi:10.1046/j.l365-2222.2003.01737.x
17. Fokkens W, Lund V, Bachert C et al. EAACI position paper on rhinosinusitis and nasal polyps. Allergy 2005; 60: 583–601. doi:10.1111/j.l398-9995.2005.00830.x
18. Chaen T, Watanabe N, Mogi G et al. Substance P and Vasoactive Intestinal Peptide in nasal secretions and plasma from patients with nasal allergy. Ann Otol Rhinol Laryn-gol 1993; 102: 16–21.
19. Undem BJ, Kajekar R, Hunter DD, Myers AC. Neural integration and allergic disease. J Allergy Clin Immunol 2000; 106: 213–20. doi:10.1067/mai.2000.110153
20. Tai CF, Baraniuk JN. Upper airway neurogenic mechanisms. Curr Opin Allergy Clin Immunol 2002; 2 (1): 11–9. doi:10.1097/00130832-200202000-00003
21. Knipping S, Riederer A. Basic autonomic and sensory innervation pattern of human nasal mucosa. In: Kaneko M (ed) Sympathetic nervous system research developments, 1st edn. Nova Science Publishers, New York, 2007; p. 185–212.
22. Turner PJ, Foreman JC. Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators Inflamm 1999; 8: 133–46. doi: 10.1080/0962935 9990469
23. Baraniuk JN, Petrie KN, Uyenphuong L et al. Neuropathol-ogy in rhinosinusitis. Am J Respir Crit Care Med 2004; 171: 5–11. doi:10.1164/rccm.200403-357OC
24. Fajac I, Braunstein G, Ickovic MR et al. Selective recruitment of eosinophils by Substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995; 50 (12): 970–5. doi:10.1111/j.1398-9995.1995.tb02509.x
25. Sato M, Fukuyama N, Sakai M, Nakazawa H. Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa-indices for severe perennial nasal allergy. Clin Exp Allergy 1998; 28: 597–605. doi:10.1046/j.!365-2222.1998.00270.x
26. Kang BH, Chen SS, Jou LS et al. Immu-nolocalization of inducible nitric oxide synthase and 3-nitrotyro-sine in the nasal mucosa of patients with rhinitis. Eur Arch Otorhinolaryngol 2000; 257 (5): 242–46. doi:10.1007/s004050050231
27. Atlas of Allergy
2. Bousquet J, Fokkens W, Burney P et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008; 63: 842–53. doi:10.1111/j.1398-9995. 2008.01715.x
3. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its aetiology, evaluation, and treatment. ENT 2000; 79 (9): 690–702.
4. Van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy 2005; 60: 1471–81. doi:10.111 l/j.1398-9995.2005.00975.x
5. Lai D, Corey JP. Vasomotor rhinitis update. Curr Opin Otolaryngol Head Neck Surg 2004; 12 (3): 243–7. doi:10.1097/01. moo.0000122310.13359.79
6. Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24: 147–54.
7. Bachert C. Persistent rhinitis-allergic or nonallergic? Allergy 2004; 59 (Suppl. 76): 11-15. doi:10.1111/j.0108-1675.2004.00389.x
8. Riechelmann H. Etagenwechsel und Folgeerkrankungen der allergischen Rhinitis. Laryngorhinootologie 1998; 77: 646–9. doi:10.1055/s-2007-997056
9. Fang SY, Shen CL. Neuropeptide innervation and neuroen-docrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998; 28: 228–32. doi:10.1046/j.1365-2222.1998. 00204.x
10. Heppt W, Preiser C, Cryer A et al. Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 2002; 44: 924–9. doi:10.1097/00043764-200210000-00011
11. Elwany S, Bumsted R. Ultrastructural observations on vaso-motor rhinitis. ORL 1987; 49: 199–205.
12. Gianessi F, Fattori B, Ursino F et al. Ultrastructural and ul-tracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 2003; 123: 943–9.
13. Numata T, Konno A, Hasegawa S et al. Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 1999; 119: 304–13. doi:10.1159/000024208
14. Sanico AM, Togias A. Noninfectious, nonallergic rhinitis NINAR: considerations on possible mechanisms. Am J Rhinol 1998; 12: 65–72. doi:10.2500/105065898782103043
15. Karlsson U, Schultz RL. Fixation of the central nervous system for electron microscopy by aldehyde perfusion. J Ultrastruct Res 1965; 12: 160–86. doi: 10.1016/80022-5320(65)80014-4
16. Powe DG, Jagger C, Kleinjan A et al. Entopy: localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003; 33: 1374–9. doi:10.1046/j.l365-2222.2003.01737.x
17. Fokkens W, Lund V, Bachert C et al. EAACI position paper on rhinosinusitis and nasal polyps. Allergy 2005; 60: 583–601. doi:10.1111/j.l398-9995.2005.00830.x
18. Chaen T, Watanabe N, Mogi G et al. Substance P and Vasoactive Intestinal Peptide in nasal secretions and plasma from patients with nasal allergy. Ann Otol Rhinol Laryn-gol 1993; 102: 16–21.
19. Undem BJ, Kajekar R, Hunter DD, Myers AC. Neural integration and allergic disease. J Allergy Clin Immunol 2000; 106: 213–20. doi:10.1067/mai.2000.110153
20. Tai CF, Baraniuk JN. Upper airway neurogenic mechanisms. Curr Opin Allergy Clin Immunol 2002; 2 (1): 11–9. doi:10.1097/00130832-200202000-00003
21. Knipping S, Riederer A. Basic autonomic and sensory innervation pattern of human nasal mucosa. In: Kaneko M (ed) Sympathetic nervous system research developments, 1st edn. Nova Science Publishers, New York, 2007; p. 185–212.
22. Turner PJ, Foreman JC. Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators Inflamm 1999; 8: 133–46. doi: 10.1080/0962935 9990469
23. Baraniuk JN, Petrie KN, Uyenphuong L et al. Neuropathol-ogy in rhinosinusitis. Am J Respir Crit Care Med 2004; 171: 5–11. doi:10.1164/rccm.200403-357OC
24. Fajac I, Braunstein G, Ickovic MR et al. Selective recruitment of eosinophils by Substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995; 50 (12): 970–5. doi:10.1111/j.1398-9995.1995.tb02509.x
25. Sato M, Fukuyama N, Sakai M, Nakazawa H. Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa-indices for severe perennial nasal allergy. Clin Exp Allergy 1998; 28: 597–605. doi:10.1046/j.!365-2222.1998.00270.x
26. Kang BH, Chen SS, Jou LS et al. Immu-nolocalization of inducible nitric oxide synthase and 3-nitrotyro-sine in the nasal mucosa of patients with rhinitis. Eur Arch Otorhinolaryngol 2000; 257 (5): 242–46. doi:10.1007/s004050050231
27. Atlas of Allergy
Авторы
Е.Ю.Радциг, Д.В.Шкляр
Кафедра оториноларингологии (зав. – член-кор. РАМН, проф, д-р мед. наук М.Р.Богомильский) педиатрического факультета ГОУ ВПО РГМУ
Кафедра оториноларингологии (зав. – член-кор. РАМН, проф, д-р мед. наук М.Р.Богомильский) педиатрического факультета ГОУ ВПО РГМУ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.